BioCryst Pharmaceuticals (European ORLADEYO Business) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
BioCryst Pharmaceuticals (European ORLADEYO Business) General Information
Description
A portfolio of medicine located in the United States. The portfolio comprises medicines for adults and children 12 years of age and older to prevent attacks of hereditary angioedema (HAE).
Contact Information
Corporate Office
- Ireland
Corporate Office
- Ireland
BioCryst Pharmaceuticals (European ORLADEYO Business) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioCryst Pharmaceuticals (European ORLADEYO Business) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioCryst Pharmaceuticals (European ORLADEYO Business) FAQs
-
Where is BioCryst Pharmaceuticals (European ORLADEYO Business) headquartered?
BioCryst Pharmaceuticals (European ORLADEYO Business) is headquartered in Ireland.
-
What industry is BioCryst Pharmaceuticals (European ORLADEYO Business) in?
BioCryst Pharmaceuticals (European ORLADEYO Business)’s primary industry is Buildings and Property.
-
Is BioCryst Pharmaceuticals (European ORLADEYO Business) a private or public company?
BioCryst Pharmaceuticals (European ORLADEYO Business) is a Private company.
-
What is the current valuation of BioCryst Pharmaceuticals (European ORLADEYO Business)?
The current valuation of BioCryst Pharmaceuticals (European ORLADEYO Business) is .
-
What is BioCryst Pharmaceuticals (European ORLADEYO Business)’s current revenue?
The current revenue for BioCryst Pharmaceuticals (European ORLADEYO Business) is .
-
Who are BioCryst Pharmaceuticals (European ORLADEYO Business)’s investors?
BioCryst Pharmaceuticals has invested in BioCryst Pharmaceuticals (European ORLADEYO Business).
-
When was BioCryst Pharmaceuticals (European ORLADEYO Business) acquired?
BioCryst Pharmaceuticals (European ORLADEYO Business) was acquired on 01-Oct-2025.
-
Who acquired BioCryst Pharmaceuticals (European ORLADEYO Business)?
BioCryst Pharmaceuticals (European ORLADEYO Business) was acquired by Neopharmed Gentili.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process